Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study (Q80390603)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 May 2007

Language	Label	Description	Also known as
English	Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study	scientific article published on 25 May 2007

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

endometrial carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic endometrial carcinoma

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

Virginia Filiaci

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kimberly K Leslie

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Meenakshi Singh

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Richard J Zaino

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

25 May 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

106

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

325-333

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Progestin regulation of cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Oral contraceptive use influences resting breast proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

A correlative morphologic study of human breast and endometrium in the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Progestational agents in the treatment of carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

The treatment of advanced endometrial cancer with hydroxyprogesterone caproate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Progesterone receptor isoform identification and subcellular localization in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Progesterone regulation of activating protein-1 transcriptional activity: a possible mechanism of progesterone inhibition of endometrial cancer cell growth.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Histologic control of biochemical steroid receptor analysis in endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Prognostic significance of hormone receptors in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Prognostic value of steroid hormone receptors for 5-year survival in stage II endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Estrogen and progesterone receptor content of endometrial carcinomas: comparison of total tissue versus cancer component analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Immunohistochemical Evaluation of Estrogen and Progesterone Receptor Content in 183 Patients with Endometrial Carcinoma: Part II: Correlation Between Biochemical and Immunohistochemical Methods and Survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Detection of progesterone receptor forms A and B by immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Estrogen and Progestin Regulation of the Progesterone Receptor Concentration in Human Endometrium*

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Oestrogen-induced progesterone receptor in human uterus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

The predictive value of progesterone receptor levels in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2007.03.042

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17532033%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80390603&oldid=1774248182"